Development of potential antiviral strategy against coxsackievirus B4
Coxsackievirus B4 (CVB4) can cause a broad range of diseases such as aseptic meningitis, meningoencephalitis, myocarditis, hepatitis, pancreatitis, gastroenteritis, necrotizing enterocolitis, pneumonia and sudden death in the neonates. CVB4 has also been implicated as a possible etiological agent fo...
Saved in:
Main Authors: | Tan, E.L., Wong, A.P.Y., Poh, C.L. |
---|---|
Format: | Article |
Published: |
Elsevier
2010
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/14188/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiviral peptides against dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022) -
Development of novel antiviral peptides against dengue serotypes 1-4
by: Lee, Michelle Felicia, et al.
Published: (2023) -
Development of antiviral strategies for treatment of chronic hepatitis B
by: Seow, Heng Fong, et al.
Published: (2002) -
Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
by: Tan, C.W., et al.
Published: (2012) -
Pathological findings in a mouse model for Coxsackievirus A16 infection
by: Hooi, Y.T., et al.
Published: (2015)